94781-89-2 Usage
Uses
Used in Skincare Products:
1-Hydroxy-6-oxo-1,6-dihydro-pyridine-2-carboxylic acid is utilized as an active ingredient in skincare products for its ability to improve skin texture, reduce the appearance of fine lines and wrinkles, and fade hyperpigmentation. Its antioxidant and anti-inflammatory properties make it a popular choice for enhancing skin health and appearance.
Used in Therapeutic Applications:
In the medical field, 1-Hydroxy-6-oxo-1,6-dihydro-pyridine-2-carboxylic acid is employed as a potential treatment for various skin conditions, including acne, rosacea, and eczema. Its beneficial properties contribute to the management and improvement of these conditions, offering a natural and effective alternative for skin health.
Used in Nutritional Supplements:
As a derivative of vitamin B3, 1-Hydroxy-6-oxo-1,6-dihydro-pyridine-2-carboxylic acid is used in nutritional supplements to support overall health. It aids in the metabolism of amino acids and fats, contributing to energy production and the maintenance of a healthy nervous and digestive system.
Used in Pharmaceutical Development:
The therapeutic potential of 1-Hydroxy-6-oxo-1,6-dihydro-pyridine-2-carboxylic acid is also recognized in the development of pharmaceuticals. Its antioxidant and anti-inflammatory properties are being explored for the treatment of various conditions, highlighting its versatility and importance in the healthcare industry.
Check Digit Verification of cas no
The CAS Registry Mumber 94781-89-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,4,7,8 and 1 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 94781-89:
(7*9)+(6*4)+(5*7)+(4*8)+(3*1)+(2*8)+(1*9)=182
182 % 10 = 2
So 94781-89-2 is a valid CAS Registry Number.
94781-89-2Relevant academic research and scientific papers
Synthesis of tetradentate mixed bisphosphonates - New hydroxypyridinonate ligands for metal chelation therapy
Bailly, Théodorine,Burgada, Ramon,Prangé, Thierry,Lecouvey, Marc
, p. 189 - 192 (2007/10/03)
In a general study for developing better drugs suitable for Fe, Al, Co or lanthanide chelation therapy experiments, new mixed bisphosphonate-hydroxy pyridonates were synthesized. We demonstrate that the method using amidation reaction and dealkylation by concentrated hydrochloric acid gives excellent results for amino bisphosphonic acid ligands having at least two carbons between the amino group and the methylene bisphosphonic acid group.
